Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-013721
Filing Date
2018-03-15
Accepted
2018-03-15 19:17:21
Documents
1
Period of Report
2018-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3519
  Complete submission text file 0001140361-18-013721.txt   5012
Mailing Address 7000 SHORELINE COURT SUITE 371 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 371 SOUTH SAN FRANCISCO CA 94080 650-800-3636
Achaogen Inc (Issuer) CIK: 0001301501 (see all company filings)

EIN.: 680533693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACHAOGEN, INC. 7000 SHORELINE COURT, SUITE 371 SOUTH SAN FRANCISCO CA 94080
Business Address
Hillan Kenneth J. (Reporting) CIK: 0001600359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36323 | Film No.: 18693828